Discovery of a novel axis through which multi-walled carbon nanotubes (MWCNTs) elicit toxicity in human macrophages, involving the propagation of inflammatory signalling via the Siglec-14-DAP12-Syk pathway, and how it may be controlled pharmacologically.
References
Dong, J. & Ma, Q. Nanotoxicol. 13, 1244–1274 (2019).
Wang, S., Ma, J., Guo, S., Huang, Y. & Cao, Y. NanoImpact 20, 100270 (2020).
Sun, B. et al. Small 11, 2087–2097 (2015).
Yamaguchi, S. I. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-023-01363-w (2023).
Omori, S. et al. Cell Rep. 34, 108734 (2021).
Duan, S. & Paulson, J. C. Annu. Rev. Immunol. 38, 365–395 (2020).
Angata, T., Hayakawa, T., Yamanaka, M., Varki, A. & Nakamura, M. FASEB J. 20, 1964–1973 (2006).
Chang, Y. C. et al. J. Mol. Med. 92, 951–959 (2014).
Shannahan, J. H. et al. Small 9, 2171–2181 (2013).
Ali, S. R. et al. J. Exp. Med. 211, 1231–1242 (2014).
Spence, S. et al. Sci. Transl Med. 7, 303ra140–303ra140 (2015).
Stanczak, M. A. & Läubli, H. Mol. Aspects Med. 90, 101112 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.K.G. and C.J.S. own shares in Aviceda Therapeutics and Avilect Biosciences.
Rights and permissions
About this article
Cite this article
Greene, M.K., Scott, C.J. Carbon nanotubes activate inflammatory signalling through binding to Siglec-14. Nat. Nanotechnol. 18, 544–545 (2023). https://doi.org/10.1038/s41565-023-01420-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-023-01420-4
- Springer Nature Limited